Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs FDC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA FDC NATCO PHARMA/
FDC
 
P/E (TTM) x 13.3 23.9 55.8% View Chart
P/BV x 3.5 3.5 100.3% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 NATCO PHARMA   FDC
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
FDC
Mar-23
NATCO PHARMA/
FDC
5-Yr Chart
Click to enlarge
High Rs847318 266.5%   
Low Rs502229 219.1%   
Sales per share (Unadj.) Rs148.4107.5 138.0%  
Earnings per share (Unadj.) Rs39.211.7 335.5%  
Cash flow per share (Unadj.) Rs48.214.0 343.4%  
Dividends per share (Unadj.) Rs5.500-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs267.1119.5 223.6%  
Shares outstanding (eoy) m182.47165.91 110.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.52.5 178.7%   
Avg P/E ratio x17.223.4 73.5%  
P/CF ratio (eoy) x14.019.5 71.8%  
Price / Book Value ratio x2.52.3 110.3%  
Dividend payout %14.00-   
Avg Mkt Cap Rs m123,04945,368 271.2%   
No. of employees `000NANA-   
Total wages/salary Rs m4,8673,909 124.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,07117,838 151.8%  
Other income Rs m1,285512 250.8%   
Total revenues Rs m28,35618,350 154.5%   
Gross profit Rs m9,1172,496 365.3%  
Depreciation Rs m1,638389 420.7%   
Interest Rs m14541 354.8%   
Profit before tax Rs m8,6192,578 334.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,466640 229.2%   
Profit after tax Rs m7,1531,938 369.0%  
Gross profit margin %33.714.0 240.7%  
Effective tax rate %17.024.8 68.5%   
Net profit margin %26.410.9 243.2%  
BALANCE SHEET DATA
Current assets Rs m30,00314,431 207.9%   
Current liabilities Rs m6,8317,296 93.6%   
Net working cap to sales %85.640.0 214.0%  
Current ratio x4.42.0 222.1%  
Inventory Days Days63265 24.0%  
Debtors Days Days115251 46.0%  
Net fixed assets Rs m26,57117,347 153.2%   
Share capital Rs m365166 220.0%   
"Free" reserves Rs m48,37319,655 246.1%   
Net worth Rs m48,73819,820 245.9%   
Long term debt Rs m06 0.0%   
Total assets Rs m56,57431,796 177.9%  
Interest coverage x60.464.1 94.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.6 85.3%   
Return on assets %12.96.2 207.2%  
Return on equity %14.79.8 150.1%  
Return on capital %18.013.2 136.1%  
Exports to sales %00-   
Imports to sales %10.28.5 121.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m2,7721,509 183.6%   
Fx inflow Rs m17,2563,259 529.5%   
Fx outflow Rs m2,7721,509 183.6%   
Net fx Rs m14,4841,749 828.0%   
CASH FLOW
From Operations Rs m8,4911,549 548.1%  
From Investments Rs m-4,771111 -4,284.7%  
From Financial Activity Rs m-3,630-1,800 201.7%  
Net Cashflow Rs m208-138 -150.3%  

Share Holding

Indian Promoters % 49.7 69.7 71.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.0 10.2 245.0%  
FIIs % 13.7 2.4 564.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 30.3 165.8%  
Shareholders   207,571 55,341 375.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs FDC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs FDC Share Price Performance

Period Natco Pharma FDC S&P BSE HEALTHCARE
1-Day -2.11% 1.06% 1.18%
1-Month -3.19% -4.50% -0.75%
1-Year 72.80% 69.82% 61.82%
3-Year CAGR 4.96% 14.77% 18.16%
5-Year CAGR 10.96% 20.71% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the FDC share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of FDC the stake stands at 69.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of FDC.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

FDC paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of FDC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.